CHEBI:143343 - 5-(2-chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one
Main |
|
ChEBI Ontology |
|
Automatic Xrefs |
|
Reactions |
|
Pathways |
|
Models |
|
This entity has been annotated by a third party. If you would like more
information added to this entry, please contact ChEBI via
email
or
GitHub.
InChI=1S/C15H12ClN3O3/c16- 12- 4- 2- 1- 3- 10(12) 15- 11- 7- 9(19(21) 22) 5- 6- 13(11) 18- 14(20) 8- 17- 15/h1- 7,21- 22H,8H2,(H,18,20) |
QKPRGUMFCHDCOK-UHFFFAOYSA-N |
ClC1=C(C2=NCC(=O)NC3=C2C=C(N(O)O)C=C3)C=CC=C1 |
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via benzodiazepine )
|
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via benzodiazepine )
|
|
View more via ChEBI Ontology
Outgoing
|
5-(2-chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one
(CHEBI:143343)
is a
1,4-benzodiazepinone
(CHEBI:35500)
5-(2-chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one
(CHEBI:143343)
is a
monochlorobenzenes
(CHEBI:83403)
|
|
|